MCID: URN022
MIFTS: 32

Urinary Tract Infections, Recurrent

Categories: Infectious diseases, Nephrological diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Urinary Tract Infections, Recurrent

MalaCards integrated aliases for Urinary Tract Infections, Recurrent:

Name: Urinary Tract Infections, Recurrent 57
Recurrent Urinary Tract Infections 28 5
Urinary Tract Infections, Recurrent, Susceptibility to 57
Urinary Tract Infection Recurrent 53
Recurrent Urinary Tract Infection 71

Classifications:



External Ids:

OMIM® 57 603806
UMLS 71 C0262655

Summaries for Urinary Tract Infections, Recurrent

MalaCards based summary: Urinary Tract Infections, Recurrent, also known as recurrent urinary tract infections, is related to urinary tract infection and urachal diverticulum. An important gene associated with Urinary Tract Infections, Recurrent is EBF3 (EBF Transcription Factor 3). The drugs Estradiol and Polyestradiol phosphate have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, kidney and prostate.

More information from OMIM: 603806

Related Diseases for Urinary Tract Infections, Recurrent

Diseases in the Urinary Tract Infection family:

Urinary Tract Infections, Recurrent

Diseases related to Urinary Tract Infections, Recurrent via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 163)
# Related Disease Score Top Affiliating Genes
1 urinary tract infection 11.4
2 urachal diverticulum 11.4
3 hand-foot-genital syndrome 11.4
4 bladder dysfunction, autonomic, with impaired pupillary reflex and secondary cakut 11.4
5 hypomagnesemia 3, renal 11.4
6 polycystic kidney disease 11.2
7 ectrodactyly and ectodermal dysplasia without cleft lip/palate 11.2
8 ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 1 11.2
9 lacrimoauriculodentodigital syndrome 11.2
10 xanthinuria 11.2
11 cakut 11.2
12 rectal duplication 11.2
13 cystitis 10.8
14 bacteriuria 10.8
15 pyelonephritis 10.7
16 vesicoureteral reflux 10.7
17 neurogenic bladder 10.6
18 klebsiella infection 10.6
19 interstitial cystitis 10.5
20 nephrolithiasis, calcium oxalate 10.5
21 pyuria 10.5
22 chronic pyelonephritis 10.4
23 urolithiasis 10.4
24 acute pyelonephritis 10.4
25 hypoascorbemia 10.3
26 rickets 10.3
27 postmenopausal atrophic vaginitis 10.3
28 prostatitis 10.3
29 rhabdomyosarcoma 2 10.2
30 drug allergy 10.2
31 hydronephrosis 10.2
32 acute cystitis 10.2
33 trigonitis 10.2
34 chronic cystitis 10.2
35 urethral stricture 10.2
36 urinary tract obstruction 10.2
37 cystitis cystica 10.2
38 spinal cord injury 10.2
39 adult syndrome 10.2
40 bladder cancer 10.2
41 cone-rod dystrophy 2 10.2
42 congenital hemidysplasia with ichthyosiform erythroderma and limb defects 10.2
43 prostatic hyperplasia, benign 10.2
44 myelomeningocele 10.2
45 overactive bladder syndrome 10.2
46 hypospadias 10.2
47 bladder calculus 10.2
48 detrusor sphincter dyssynergia 10.2
49 diarrhea 10.2
50 trichomoniasis 10.2

Graphical network of the top 20 diseases related to Urinary Tract Infections, Recurrent:



Diseases related to Urinary Tract Infections, Recurrent

Symptoms & Phenotypes for Urinary Tract Infections, Recurrent

Clinical features from OMIM®:

603806 (Updated 08-Dec-2022)

Drugs & Therapeutics for Urinary Tract Infections, Recurrent

Drugs for Urinary Tract Infections, Recurrent (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 62)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
2
Polyestradiol phosphate Approved Phase 4 28014-46-2
3 Apricot Approved Phase 4
4
Methyltestosterone Approved Phase 4 58-18-4 6010
5
Testosterone undecanoate Approved, Investigational Phase 4 5949-44-0 21873174 65157
6
Testosterone enanthate Approved Phase 4 315-37-7 9416
7
Testosterone Approved, Investigational Phase 4 58-22-0 5408 6013
8
Methenamine Approved, Vet_approved Phase 4 100-97-0 4101
9
Amikacin Approved, Investigational, Vet_approved Phase 4 37517-28-5, 39831-55-5 37768
10
Cephalexin Approved, Investigational, Vet_approved Phase 4 15686-71-2 27447
11
Fosfomycin Approved Phase 4 23155-02-4 446987
12
Tobramycin Approved, Investigational Phase 4 32986-56-4 36294
13 Estradiol 3-benzoate Phase 4
14 Estradiol 17 beta-cypionate Phase 4
15 Estrogens, Conjugated (USP) Phase 4
16 Anti-Infective Agents, Local Phase 4
17 Hormones Phase 4
18 Hormone Antagonists Phase 4
19 Androgens Phase 4
20 Emollients Phase 4
21 Testosterone 17 beta-cypionate Phase 4
22 Methenamine mandelate Phase 4
23 Methenamine hippurate Phase 4
24 Antitubercular Agents Phase 4
25 Estrogens Phase 2, Phase 3
26
Heparin, bovine Approved, Investigational, Withdrawn Phase 1, Phase 2 9005-49-6 22833565 9812414 772
27
Cholecalciferol Approved, Nutraceutical, Vet_approved Phase 2 67-97-0, 1406-16-2 5280795 10883523
28
Ergocalciferol Approved, Nutraceutical Phase 2 50-14-6 5280793
29 Soy Bean Phase 2
30 Vitamins Phase 2
31 Fibrinolytic Agents Phase 1, Phase 2
32 Calcium, Dietary Phase 1, Phase 2
33 Anticoagulants Phase 1, Phase 2
34 Calcium heparin Phase 1, Phase 2
35
Vitamin D2 Phase 2 3249
36 Trace Elements Phase 2
37 Calciferol Phase 2
38 Ergocalciferols Phase 2
39 Micronutrients Phase 2
40 Vaccines Phase 2
41 Contraceptive Agents Phase 2
42
Calcium Nutraceutical Phase 1, Phase 2 7440-70-2 271
43 Anthocyanidin Phase 1
44
Proanthocyanidin Phase 1 21881649
45
Procyanidin Phase 1 4852-22-6 147299
46
Levofloxacin Approved, Investigational 100986-85-4 149096
47
Ofloxacin Approved 82419-36-1 4583
48
Amoxicillin Approved, Vet_approved 26787-78-0 33613
49
Cefuroxime Approved 55268-75-2 5479529
50
Clavulanic acid Approved, Vet_approved 58001-44-8 5280980

Interventional clinical trials:

(show top 50) (show all 71)
# Name Status NCT ID Phase Drugs
1 A Randomised, Double-blind, Placebo Controlled Trial Evaluating the Effectiveness of a Cranberry Concentrate (CranrichTM) in Preventing Recurrent Urinary Tract Infections in Adult Women Unknown status NCT02454309 Phase 4
2 Low Dose Estriol With Lactobacilli (Gynoflor) Treatment for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized, Open, Parallel-Group Study Unknown status NCT00900653 Phase 4 Gynoflor E (low dose estriol with lactobacillus)
3 Recurrent Urinary Tract Infections in Children: Bacterial Identification, Antibiotic Susceptibility Profiling and Cytokine Levels Associated With Antibiotic Prophylaxis Completed NCT02357758 Phase 4 Antibiotic Prophylaxis
4 The Effects of Vaginal Estrogen and a Nonhormonal Alternative on the Vaginal and Urinary Microbiome in Women With Genitourinary Syndrome of Menopause: A Randomized Controlled Trial Completed NCT02869165 Phase 4 Conjugated equine estrogen topical cream;Apricot kernel oil
5 Antibiotic Treatment for Intermittent Bladder Catheterisation: A Randomised Controlled Trial of Once Daily Prophylaxis Completed NCT02145338 Phase 4 Nitrofurantoin or Trimethoprim or Cefalexin
6 Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs Completed NCT03077711 Phase 4 Trimethoprim;Methenamine hippurate
7 Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized Clinical Trial Completed NCT01958073 Phase 4 Conjugated Estrogen Vaginal Cream;Estradiol Ring;Placebo
8 Non-antimicrobial Alternative in Prophylaxis of Recurrent Urinary Tract Infections: a Prospective, Randomised-controlled, Double-blinded, Multicentre Study Recruiting NCT04095572 Phase 4 intravesical instillation with HA-CS;intravesical instillation of sterile purified water
9 Efficacy and Mechanism of Action of Methenamine Hippurate (Hiprex™) in the Management of Recurrent Urinary Tract Infections in Women Recruiting NCT04709601 Phase 4 Hiprex
10 Prevention of Recurrent Urinary Tract Infection Using Vaginal Testosterone Versus Placebo Recruiting NCT04807894 Phase 4 Vaginal Cream with Applicator
11 The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing Due to New Episodes of Urinary Tract Infections (UTI) in Elderly Women With Recurrent UTI - a Triple- Blinded, Randomized Placebo-controlled Phase IV Study Enrolling by invitation NCT04077580 Phase 4 Methenamine Hippurate 1000 MG
12 Intravesical Antibiotic Instillations Versus Oral Suppression for the Treatment of Recurrent Urinary Tract Infections in Post-menopausal Women Not yet recruiting NCT04285320 Phase 4 Intravesical antibiotic instillation;Antibiotic oral suppressive therapy
13 Mechanisms of Successful Vaginal Estrogen Prophylaxis for Postmenopausal Women With Recurrent Urinary Tract Infections: Urogenital Microbiota and Host Immune Responses Not yet recruiting NCT05551949 Phase 4 Vaginal estradiol tablets
14 Preventing Recurrent Urinary Tract Infections With α-D-mannose: a Prospective, Randomized, Double-blinded Placebo-controlled Trial Terminated NCT03497598 Phase 4 Mannose;Lactose
15 A Randomized, Double-blind, Placebo Controlled Trial Evaluating the Effectiveness of a Cranberry Concentrate in Preventing Recurrent Urinary Tract Infections in Adult Women Withdrawn NCT01881165 Phase 4 Cranberry;Placebo
16 INtravesical Antimicrobial Agents Versus STANDard Oral Antibiotics for the Treatment of Acute Urinary Tract Infection in Women With Recurrent Urinary Tract Infection (INSTANT Study) Withdrawn NCT03299387 Phase 4 Nitrofurantoin;Gentamicin
17 Recurrent Urinary Tract Infections in Adult Women: a Pilot Study With Oral D Mannose Completed NCT01808755 Phase 3 trimethoprim/sulfamethoxazole
18 Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women (RUTI) in Post-menopausal Women With Signs of Urogenital Ageing (UGA) Terminated NCT00560924 Phase 3 estradiol, 25 mcg
19 Randomized, Controlled Trial to Determine the Efficacy of Nutraceutical vs Control as Non-antibiotic Prophylaxis for Recurrent Urinary Tract Infection in Postmenopausal Women Using Vaginal Estrogen Therapy Terminated NCT03395288 Phase 2, Phase 3 D-Mannose
20 A Randomized, Double-blind, Placebo-controlled Trial on the Preventive Effect of Intravaginal Prasterone (DHEA, Intrarosa®) on Recurrent Urinary Tract Infections in Women With Genitourinary Syndrome of Menopause Withdrawn NCT03854396 Phase 3 Prasterone;Placebo
21 A Randomised, Double-blind, Placebo Controlled Study to Investigate the Efficacy and Safety of High Strength Cranberry (Pacran®) in Women With Recurrent Urinary Tract Infections (Cystitis) Completed NCT03042273 Phase 2
22 Phase 2 Clinical Trial of Vaginal Mucosal Immunization for Recurrent Urinary Tract Infections Completed NCT00261248 Phase 2
23 Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infections Completed NCT00305227 Phase 2 Lactin-V;Placebo
24 Fecal Microbiota Transplantation Using RBX2660 for the Prevention of Recurrent Urinary Tract Infections Due to Multidrug Resistant Organisms Completed NCT03367910 Phase 1, Phase 2 Fecal microbiota transplant
25 Recurrent Urinary Tract Infections and Heparin: a Double-blind Randomized Trial (RUTIH Trial) Recruiting NCT02246270 Phase 1, Phase 2 Intravesical Heparin
26 A Clinical Trial to Determine the Extent to Which Probiotic Therapy Reduces Side Effects of Antibiotic Prophylaxis in Pediatric Neurogenic Bladder Patients With a History of Recurrent Urinary Tract Infections Recruiting NCT02044965 Phase 1, Phase 2 Probiotic
27 Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections: a Multicenter, Randomized, Placebo-controlled Trial Recruiting NCT04859621 Phase 2 Vitamin D3 4000 IU;Vitamin D3 2000 IU;Placebo
28 Protocol 19-01: Canadian, Single Centre, Pilot, Open Label Study to Evaluate the Efficacy and Safety of the Bacterial Vaccine Uromune in Treating Recurrent Urinary Tract Infections in Women. Active, not recruiting NCT04096820 Phase 2
29 Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections: TAPER (Techniques of APplying Vaginal Estrogen for Prevention of Recurrent Urinary Tract Infections) Trial Not yet recruiting NCT05472779 Phase 2 Periurethral application of estradiol cream;Intravaginal application of estradiol cream
30 H-23187: Probiotic Prophylaxis Against Recurrent Pediatric Urinary Tract Infection Withdrawn NCT00789464 Phase 2 trimethoprim/sulfamethoxazole
31 Single Centre Open-label Feasibility Study Evaluating the Use of D-mannose in Multiple Sclerosis Unknown status NCT02490046 Phase 1
32 Recurrent Urinary Tract Infection Prevention With Biologic Cranberry Extract Intake Standardized in Proanthocyanidins: A Double-blind Clinical Trial Unknown status NCT02572895 Phase 1
33 Evaluation of a Candidate Vaccine Against Uropathogenic Escherichia Coli in Women With a Clinical History of Recurrent Urinary Tract Infection Completed NCT02289794 Phase 1
34 INTRAVESICAL ADMINISTRATION OF COMBINED HYALURONIC ACID (HA) AND CHONDROITIN SULPHATE (CS) vs. STANDARD OF CARE FOR THE TREATMENT OF RECURRENT URINARY TRACT INFECTIONS (RUTIs) Unknown status NCT02016118
35 Identification of Predictive Blood Biomarkers of Recurrent Urinary Tract Infections Unknown status NCT03819712
36 Prophylactic Use of Cranberries in Recurrent Bacterial Cystitis in Women: A Randomized, Comparative, Study. Unknown status NCT03032003
37 Hyaluronate for the Treatment and Prevention of Recurrent Urinary Tract Infection in Women Suffering Atrophic Vaginitis Unknown status NCT03981458
38 Study on Treatment of Recurrent Urinary Tract Infection by Traditional Chinese Medicine Unknown status NCT01745328 LVX-AMX;TCM
39 Safety and Tolerability of Controlled Human Urine Transfusion for Urinary Tract Infection Prevention (SHUTUP): a Pilot Study Unknown status NCT03142295
40 Cross-sectional Survey on Patients With Urinary Tract Infections in Puy-de-Dôme : Epidemiology of Recurrent Urinary Tract Infections and Risk Factors Completed NCT04361864
41 Observational Study With Mode of Action-Analysis of Cystorenal Cranberry Extract in Patients With Recurrent Urinary Tract Infections Completed NCT03019874
42 Segmental and Ear Acupuncture for Prevention of Recurrent Urinary Tract Infections(SARUTI Study): a Multicenter Randomized Controlled Trial Completed NCT02705495 Cranberry products
43 A Randomized, Double-blind, Placebo-controlled Clinical Study to Assess the Use of Nanotechnology Structured Water Magnalife for the Prevention of Recurrent Urinary Tract Infections. Completed NCT04306731 Trimethoprim
44 Oral D Mannose in the Prevention and Treatment of Recurrent Urinary Tract Infections: a Systematic Review Completed NCT03790254
45 Induced Asymptomatic E. Coli 83972 Bacteriuria in Patients With Recurrent Urinary Tract Infections and Bladder Dysfunction- is There a Protective Effect Against Recurrent Symptomatic Infections? A Blinded Placebo Controlled Cross-over Study. Completed NCT00927316
46 The Effect of Increased Water Intake on the Frequency of the Clinical Recurrent Urinary Tract Infections in Pre-menopausal Women: S-HYDRACYST Completed NCT02444975
47 The Efficacy of Preventive Antibiotic Treatment During the Puerperium Among Pregnant Women With Recurrent Urinary Tract Infections Completed NCT01507974 Preventive antibiotic treatment- NITROFURANTOIN;Preventive antibiotic treatment- CEPHALEXIN;PREVENTIVE TREATMENT- AMOXICILLIN;PREVENTIVE TREATMENT- AMOXICILLIN AND CLAVULANATE POTASSIUM;PREVENTIVE TREATMENT- CEFUROXIME;PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM
48 Clinical Value of Homeopathic Assessment and Treatment for Prophylaxis of Recurrent Urinary Tract Infections in Persons With Spinal Cord Injury Completed NCT01477502
49 Association Between Deficiency of MBL (Mannose-Binding Lectin) and Polymorphisms in MBL2 Gene to Urinary Tract Infection Completed NCT00678028
50 Pain-perception During Outpatient cystoscopy-a Prospective Controlled Study Completed NCT01663181

Search NIH Clinical Center for Urinary Tract Infections, Recurrent

Genetic Tests for Urinary Tract Infections, Recurrent

Genetic tests related to Urinary Tract Infections, Recurrent:

# Genetic test Affiliating Genes
1 Recurrent Urinary Tract Infections 28

Anatomical Context for Urinary Tract Infections, Recurrent

Organs/tissues related to Urinary Tract Infections, Recurrent:

MalaCards : Spinal Cord, Kidney, Prostate, Pancreas, Appendix, Liver, Lymph Node

Publications for Urinary Tract Infections, Recurrent

Articles related to Urinary Tract Infections, Recurrent:

(show top 50) (show all 2236)
# Title Authors PMID Year
1
Evaluation of a familial predisposition to recurrent urinary tract infections in women. 62 57
10232756 1999
2
The role of excretory urography and cystoscopy in the evaluation and management of women with recurrent urinary tract infection. 62 57
7354514 1980
3
Whole-genome sequencing of patients with rare diseases in a national health system. 5
32581362 2020
4
URINARY TRACT INFECTION IN SCHOOL CHILDREN: AN EPIDEMIOLOGIC, CLINICAL AND LABORATORY STUDY. 57
14129871 1964
5
Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections. 53 62
16339057 2005
6
Xanthogranulomatous Pyelonephritis - A Diagnostic and Therapeutic Dilemma. 62
36473546 2022
7
Vaginal Hormone Therapy for Conditions of the Lower Urinary Tract. 62
36454371 2022
8
Recurrent E. coli Urinary Tract Infections in Nursing Homes: Insight in Sequence Types and Antibiotic Resistance Patterns. 62
36421283 2022
9
Concomitant occurrence of pyelocalyceal diverticulum and ipsilateral large sized orthotopic ureterocele in an adult: a rare association. 62
35416624 2022
10
Methenamine hippurate to prevent recurrent urinary tract infections in older women: protocol for a randomised, placebo-controlled trial (ImpresU). 62
36319057 2022
11
Long-term efficacy of complete trigonal electrofulguration for women with recurrent urinary tract infections. 62
36321758 2022
12
Preventive effect of methenamine in women with recurrent urinary tract infections - a case-control study. 62
36369890 2022
13
The efficacy and safety of intravesical chondroitin sulphate solution in recurrent urinary tract infections. 62
36424583 2022
14
Draft Genome Sequence of Staphylococcus epidermidis UMB7543, Isolated from a Female Patient with Recurrent Urinary Tract Infections. 62
36354363 2022
15
A Focus on Long-Term Follow-Up of Immunoprophylaxis to Recurrent Urinary Tract Infections: 10 Years of Experience with MV140 Vaccine in a Cohort of 1003 Patients Support High Efficacy and Safety. 62
36472057 2022
16
Role of Flexible Cystoscopy in the Management of Postmenopausal Women With Recurrent Urinary Tract Infections. 62
35944653 2022
17
Guideline of guidelines: management of recurrent urinary tract infections in women. 62
35579121 2022
18
Duplex renal collecting system presenting with hydroureteronephrosis following pelvic organ prolapse and sacrocolpopexy in an adult female. 62
36033162 2022
19
Laser treatment for genitourinary syndrome of menopause: Scientific Impact Paper No. 72 (July 2022): Scientific Impact Paper No. 72 (July 2022). 62
35892242 2022
20
[Urinary tract infections in patients with neurogenic lower urinary tract dysfunction]. 62
36448946 2022
21
Interaction of Neutrophils and Biofilm Formed by Uropathogenic Escherichia coli Strains with Different Pathogenic Potential. 62
36437333 2022
22
Comparison of bidirectional barbed versus conventional monofilament suture material for closure of feline perineal urethrostomies. 62
36325412 2022
23
Pharmacodynamics of D-mannose in the prevention of recurrent urinary infections. 62
35416116 2022
24
Recurrent antimicrobial exposure and acute psychosis. 62
35849768 2022
25
IUCD as bladder stone. 62
35770316 2022
26
Prospective multicentre randomized double-blind placebo-controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections. 62
36181584 2022
27
d-mannosuria levels measured 1 h after d-mannose intake can select out favorable responders: A pilot study. 62
36183388 2022
28
New Onset Diabetes in an Older Patient: An Unforeseen Phenomenon. 62
36171664 2022
29
UPEC Colonic-Virulence and Urovirulence Are Blunted by Proanthocyanidins-Rich Cranberry Extract Microbial Metabolites in a Gut Model and a 3D Tissue-Engineered Urothelium. 62
35972287 2022
30
Percutaneous Tibial Nerve Stimulation Improves Lower Urinary Tract Dysfunction and Infection Rate in a Kidney Transplant Recipient With Augmentation Cystoplasty: A Case Report and Literature Review. 62
36319495 2022
31
A Review of Urinary Tract Endometriosis. 62
36048338 2022
32
The use of intravesical antibiotics in the treatment of recurrent urinary tract infections: A case series. 62
36300868 2022
33
Nephrological and urological symptoms in patients with Robinow syndrome - a report of two cases. 62
36283013 2022
34
Supraphysiologic Vaginal Estrogen Therapy in Aged Mice Mitigates Age-Associated Bladder Inflammatory Response to Urinary Tract Infections. 62
36384972 2022
35
Revision ureteroneocystostomy in pediatric renal transplant patients for symptomatic vesicoureteral reflux and its effect on recurrent hospitalizations. 62
36167649 2022
36
The Cumulative Detrimental Effect of COVID-19 Pneumonia in a Patient with Myasthenic Crisis: A Case Report and Overview of the Literature. 62
36294917 2022
37
[What to do about recurrent urinary tract infections]. 62
36030788 2022
38
Electro-fulguration for extensive inflammatory bladder lesions in post-menopausal women with antibiotic-recalcitrant recurrent urinary tract infections. 62
36166061 2022
39
Missed urethral duplication associated with hypospadias, post-hypospadias repair urethral stenosis, and recurrent urinary tract infections in an adult: a case report. 62
36180877 2022
40
Intravesical gentamicin instillation in the prevention of recurrent urinary tract infections in children with neurogenic bladder- a single-center retrospective observational study. 62
36216695 2022
41
Horseshoe Kidney With a Documented Giant Calculi: A Case Report. 62
36258992 2022
42
Association of Kidney Stones and Recurrent UTIs: the Chicken and Egg Situation. A Systematic Review of Literature. 62
35877059 2022
43
Fluorescence kinetics study of twice laser irradiation based HpD-PDT for nonmelanoma skin cancer. 62
35391497 2022
44
Phenotypic and genotypic distribution of ESBL, AmpC β-lactamase and carbapenemase-producing Enterobacteriaceae in community-acquired and hospital-acquired urinary tract infections in Sri Lanka. 62
35667644 2022
45
Management of Recurrent Cystitis in Women: When Prompt Identification of Risk Factors Might Make a Difference. 62
35135727 2022
46
Diagnostic yield of uroendoscopy compared to ultrasonography for evaluating lower urinary tract disorders in dogs. 62
35986564 2022
47
The Pseudo-Bladder: A Case of the Prostatic Urethra Masquerading as the Bladder. 62
36179861 2022
48
Body contouring abdominoplasty for augmentation enterocystoplasty with continent cutaneous urinary diversion in an obese adolescent patient: A case report. 62
35832859 2022
49
Hernia Causing Ureteral Obstruction With Hydronephrosis and Subsequent Urinary Tract Infection and Sepsis. 62
36304363 2022
50
Complications associated with patent urachus in starting of peritoneal dialysis. 62
36086985 2022

Variations for Urinary Tract Infections, Recurrent

ClinVar genetic disease variations for Urinary Tract Infections, Recurrent:

5
# Gene Name Type Significance ClinVarId dbSNP ID Position
1 EBF3 NM_001375380.1(EBF3):c.280_283del (p.Glu94fs) DEL Pathogenic
375502 rs1057519521 GRCh37: 10:131761639-131761642
GRCh38: 10:129963375-129963378

Expression for Urinary Tract Infections, Recurrent

Search GEO for disease gene expression data for Urinary Tract Infections, Recurrent.

Pathways for Urinary Tract Infections, Recurrent

GO Terms for Urinary Tract Infections, Recurrent

Sources for Urinary Tract Infections, Recurrent

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....